The award will also be used to fund secondments for scientists and engineers to spend time in a business environment: improving their knowledge and skills and returning to the lab with a better understanding of the way companies operate and the challenges they face. It will also be used to support the further development of intellectual property arising from research funded by the EPSRC at Nottingham.
The University already has an excellent track record in ‘spinning out’ promising EPSRC-funded research into successful businesses. Companies such as Promethean Particles, Monica Healthcare, Critical Pharmaceuticals and Regentec all started life as Nottingham research projects and have proven their worth in markets as diverse as healthcare, nanoscience, pharmaceuticals and tissue regeneration.
Click here for the full story